Nos produits favorisant la Fertilité
pcos-treatment
Inosia

INOSIA est une combinaison unique de produits entièrement naturels, conçue pour réduire les symptômes du syndrome des ovaires polykystiques (SOPK). De nombreuses études scientifiques reconnaissent que les plantes médicinales et les sensibilisateurs naturels d’insuline aident les femmes à soulager leurs symptômes et leur permettent d’améliorer leur santé reproductive.

YADTECH a regroupé, en un seul supplément, des composés naturels cliniquement reconnus pour diminuer la testostérone, favoriser l’équilibre des hormones sexuelles, maintenir une glycémie et un poids santé, régulariser le cycle menstruel, augmenter le nombre de cycles ovulatoires, améliorer la réponse ovarienne aux traitements de fertilité, la qualité des ovules, le taux de fécondation, la qualité des embryons en plus de réduire le risque d’hyperstimulation ovarienne.

Approuvé par Santé Canada. NPN : 80075282

Dose recommandée: 4 capsules par jour, pendant 3 à 6 mois



Prix: $39.99
  • Quantité:


Composition

  • Inositol
  • Myo-inositol : 300 mg
  • D-Chiro-inositol : 7,5 mg
  • N-Acetyl-L-cystéine : 25 mg
  • Chrome (Picolinate de chrome (III)) : 50 mcg
  • Vanadium (Produit de chélate de vanadium PVP) : 18,75 mcg
  • Vitex (Agnus-castus-Fruit) : 40,5 mg
  • Pivoine de Chine (Paeonia lactiflora, pivoine blanche, plant entier) : 100 mg
  • Réglisse (Racine de Glycyrrhiza glabra):15 mg
  • Actée à grappes noires (Actaea racemosa-Racine) : 5 mg

Études connexes

    March, W. A. et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25, 544-551, doi:10.1093/humrep/dep399 (2010).
  • Garg, D. & Tal, R. Inositol Treatment and ART Outcomes in Women with PCOS. Int J Endocrinol 2016, 1979654, doi:10.1155/2016/1979654 (2016).
  • Dinicola, S., Chiu, T. T., Unfer, V., Carlomagno, G. & Bizzarri, M. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. J Clin Pharmacol 54, 1079-1092, doi:10.1002/jcph.362 (2014).
  • Bevilacqua, A. et al. Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology–assisted reproduction technology. Gynecol Endocrinol 31, 441-446, doi:10.3109/09513590.2015.1006616 (2015).
  • Facchinetti, F. et al. Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. Eur J Obstet Gynecol Reprod Biol 195, 72-76, doi:10.1016/j.ejogrb.2015.09.024 (2015).
  • Fulghesu, A. M. et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril 77, 1128-1135 (2002).
  • Cheraghi, E., Mehranjani, M. S., Shariatzadeh, M. A., Esfahani, M. H. & Ebrahimi, Z. N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin. Reprod Fertil Dev 28, 723-731, doi:10.1071/RD14182 (2016).
  • Goldfine, A. B. et al. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism 49, 400-410 (2000).
  • Cicero, A. F., Tartagni, E. & Ertek, S. Nutraceuticals for metabolic syndrome management: from laboratory to benchside. Curr Vasc Pharmacol 12, 565-571 (2014).
  • Anton, S. D. et al. Effects of chromium picolinate on food intake and satiety. Diabetes Technol Ther 10, 405-412, doi:10.1089/dia.2007.0292 (2008).
  • Lee, N. A. & Reasner, C. A. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17, 1449-1452 (1994).
  • Roeback, J. R., Jr., Hla, K. M., Chambless, L. E. & Fletcher, R. H. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. A randomized, controlled trial. Ann Intern Med 115, 917-924 (1991).
  • Anderson, R. A. et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46, 1786-1791 (1997).
  • Anderson, R. A. Chromium in the prevention and control of diabetes. Diabetes Metab 26, 22-27 (2000).
  • Gerhard, I., Patek, A., Monga, B., Blank, A. & Gorkow, C. Mastodynon(R) bei weiblicher Sterilität. Forsch Komplementarmed 5, 272-278, doi:21154 (1998).
  • Kilicdag, E. B. et al. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int J Gynaecol Obstet 85, 292-293, doi:10.1016/j.ijgo.2004.01.001 (2004).
  • Bergmann, J., Luft, B., Boehmann, S., Runnebaum, B. & Gerhard, I. [The efficacy of the complex medication Phyto-Hypophyson L in female, hormone-related sterility. A randomized, placebo-controlled clinical double-blind study]. Forsch Komplementarmed Klass Naturheilkd 7, 190-199, doi:21343 (2000).
  • Milewicz, A. et al. [Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study]. Arzneimittelforschung 43, 752-756 (1993).
  • Kamel, H. H. Role of phyto-oestrogens in ovulation induction in women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 168, 60-63, doi:10.1016/j.ejogrb.2012.12.025 (2013).
  • Arentz, S., Abbott, J. A., Smith, C. A. & Bensoussan, A. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complement Altern Med 14, 511, doi:10.1186/1472-6882-14-511 (2014).
  • Sun, W. S. et al. In vitro stimulation of granulosa cells by a combination of different active ingredients of unkei-to. Am J Chin Med 32, 569-578, doi:10.1142/S0192415X0400220X (2004).
  • Takeuchi, T., Nishii, O., Okamura, T. & Yaginuma, T. Effect of traditional herbal medicine, shakuyaku-kanzo-to on total and free serum testosterone levels. Am J Chin Med 17, 35-44, doi:10.1142/S0192415X89000073 (1989).
  • Ushiroyama, T. et al. Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion. J Reprod Med 46, 451-456 (2001).
  • Yaginuma, T., Izumi, R., Yasui, H., Arai, T. & Kawabata, M. Effect of traditional herbal medicine on serum testosterone levels and its induction of regular ovulation in hyperandrogenic and oligomenorrheic women (author’s transl). Nihon Sanka Fujinka Gakkai Zasshi 34, 939-944 (1982).
  • Takahashi, K. & Kitao, M. Effect of TJ-68 (shakuyaku-kanzo-to) on polycystic ovarian disease. Int J Fertil Menopausal Stud 39, 69-76 (1994).
  • Armanini, D. et al. Treatment of polycystic ovary syndrome with spironolactone plus licorice. Eur J Obstet Gynecol Reprod Biol 131, 61-67, doi:10.1016/j.ejogrb.2006.10.013 (2007).

Nos produits 100% naturels